UA27229C2 - Фракція гіалуронової кислоти або її солі для застосування в офтальмології, спосіб одержання фракції натрієвої солі гіалуронової кислоти та фармацевтичний препарат для використання в офтальмології - Google Patents

Фракція гіалуронової кислоти або її солі для застосування в офтальмології, спосіб одержання фракції натрієвої солі гіалуронової кислоти та фармацевтичний препарат для використання в офтальмології

Info

Publication number
UA27229C2
UA27229C2 UA93002144A UA93002144A UA27229C2 UA 27229 C2 UA27229 C2 UA 27229C2 UA 93002144 A UA93002144 A UA 93002144A UA 93002144 A UA93002144 A UA 93002144A UA 27229 C2 UA27229 C2 UA 27229C2
Authority
UA
Ukraine
Prior art keywords
fraction
hyaluronic acid
ophthalmology
salt
purification
Prior art date
Application number
UA93002144A
Other languages
English (en)
Russian (ru)
Inventor
Ромео Ауреліо
Ромео Аурелио
Лоренці Сільвана
Лоренци Сильвана
Original Assignee
Фідія С.П.А.
Фидия С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11389548&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA27229(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Фідія С.П.А., Фидия С.П.А. filed Critical Фідія С.П.А.
Publication of UA27229C2 publication Critical patent/UA27229C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Даний винахід є новим процесом отримання високочистих фракцій гіалуронової кислоти і її солей. він стосується особливої фракції гіалуронової кислоти і її солей, зокрема, натрієвої солі, яку одержують запропонованим способом і яка має середню молекулярну вагу в межах заданого діапазону.
UA93002144A 1991-04-19 1993-06-16 Фракція гіалуронової кислоти або її солі для застосування в офтальмології, спосіб одержання фракції натрієвої солі гіалуронової кислоти та фармацевтичний препарат для використання в офтальмології UA27229C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD910077A IT1247175B (it) 1991-04-19 1991-04-19 Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.

Publications (1)

Publication Number Publication Date
UA27229C2 true UA27229C2 (uk) 2000-08-15

Family

ID=11389548

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93002144A UA27229C2 (uk) 1991-04-19 1993-06-16 Фракція гіалуронової кислоти або її солі для застосування в офтальмології, спосіб одержання фракції натрієвої солі гіалуронової кислоти та фармацевтичний препарат для використання в офтальмології

Country Status (24)

Country Link
US (1) US5559104A (uk)
EP (1) EP0535200B1 (uk)
JP (1) JP2580458B2 (uk)
KR (1) KR0178544B1 (uk)
AT (1) ATE186307T1 (uk)
AU (1) AU653022B2 (uk)
BR (1) BR9205240A (uk)
CA (1) CA2084875C (uk)
CZ (1) CZ282248B6 (uk)
DE (1) DE69230242T2 (uk)
DK (1) DK0535200T3 (uk)
ES (1) ES2092971T3 (uk)
FI (1) FI104973B (uk)
GR (1) GR3032434T3 (uk)
HU (1) HU215193B (uk)
IL (2) IL101611A (uk)
IT (1) IT1247175B (uk)
NO (1) NO305520B1 (uk)
PL (1) PL168477B1 (uk)
RU (1) RU2128666C1 (uk)
SG (1) SG46515A1 (uk)
SK (1) SK280191B6 (uk)
UA (1) UA27229C2 (uk)
WO (1) WO1992018543A1 (uk)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274984B (it) * 1994-12-09 1997-07-29 Technopharma Sa Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri
IT1282219B1 (it) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
IT1287967B1 (it) 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S Preparazioni farmaceutiche per uso anestetico locale
IT1291452B1 (it) 1997-04-14 1999-01-11 Fidia Advanced Biopolymers Srl Rivestimento a base di acido ialuronico e suoi derivati per la protezione di parti elettroniche da agenti esterni
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
CN1148347C (zh) 1998-05-29 2004-05-05 骨疗国际公司 羟基-25-烯-维生素d类化合物的制备方法
DK172900B1 (da) 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
KR100836733B1 (ko) * 2002-11-15 2008-06-10 코오롱생명과학 주식회사 히알우론산 나트륨의 회수방법 및 그를 위한 장치
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
KR100577075B1 (ko) * 2004-06-16 2006-05-08 주식회사 티앤라이프시스템 칼슘염 및 인산염, 또는 인산칼슘염을 이용한 히아루론산정제방법
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
EP1786480B1 (en) * 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
DE102005030011A1 (de) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
ITPD20050242A1 (it) 2005-08-03 2007-02-04 Fidia Farmaceutici Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
KR101509139B1 (ko) * 2006-11-23 2015-04-08 주식회사 엘지생명과학 히알루론산의 정제방법
KR100894042B1 (ko) * 2007-04-13 2009-04-20 가톨릭대학교 산학협력단 설파살라진-히알루론산 혼합물의 제조방법 및 이로부터얻어진 혼합물을 포함하는 후발성 백내장 억제용 조성물
US9089592B2 (en) 2007-04-26 2015-07-28 Seikagaku Corporation Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material, a composition for evaluation of a viscoelastic material and a method for evaluation using the composition
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
WO2009063291A1 (en) * 2007-11-13 2009-05-22 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
CN103442719A (zh) * 2011-03-02 2013-12-11 电气化学工业株式会社 含透明质酸或透明质酸盐的水溶液
JP5957440B2 (ja) * 2011-03-02 2016-07-27 デンカ株式会社 ヒアルロン酸またはその塩を含む水溶液
WO2012118194A1 (ja) * 2011-03-02 2012-09-07 電気化学工業株式会社 樹脂製バレルを有するシリンジ内にヒアルロン酸又はその塩を含む水溶液を充填してなるプレフィルドシリンジ
WO2012118190A1 (ja) * 2011-03-02 2012-09-07 電気化学工業株式会社 ヒアルロン酸またはその塩を含む水溶液
JP5957441B2 (ja) * 2011-03-02 2016-07-27 デンカ株式会社 ヒアルロン酸またはその塩を含む水溶液
WO2012129461A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
RU2477138C1 (ru) * 2011-11-02 2013-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения заполняющего материала для пластической хирургии и инструментальной косметологии, заполняющий материал и способ введения заполняющего материала в проблемную зону
ITMI20120664A1 (it) 2012-04-20 2013-10-21 Anika Therapeutics Srl Biomateriali a base di gellano per l'uso come filler in chirurgia
US10723812B2 (en) 2014-02-06 2020-07-28 New York University Method for separating hyaluronan and quantifying its molecular mass distribution in biological samples
IT201600079633A1 (it) * 2016-07-28 2018-01-28 Fidia Farm Spa Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
JP2023505229A (ja) 2019-12-05 2023-02-08 シーアイエス ファーマ アクツィエンゲゼルシャフト 眼への適用のための高ヒアルロン酸塩多用途消毒溶液
RU2765951C1 (ru) * 2021-05-14 2022-02-07 Общество с ограниченной ответственностью "АВЕО" Способ очистки гиалуроната от эндотоксинов
WO2023030435A1 (en) 2021-09-01 2023-03-09 Shanghai Qisheng Biological Preparation Co., Ltd. Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4766348A (en) * 1983-06-09 1988-08-23 Gte Products Corporation Single-ended metal halogen lamp and fabrication process employing ionization potential selection of additive gases
DE3482812D1 (de) * 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
JPS6121241A (ja) * 1984-07-10 1986-01-29 オリエンタル建設株式会社 プレストレストコンクリ−ト部材組立式ラ−メン構造体における多スパン梁の構築方法
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
AU600257B2 (en) * 1986-03-21 1990-08-09 International Pharmaceutical Products, Inc. Non-inflammatory hyaluronic acid fraction and process for preparing it
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
JPH0813847B2 (ja) * 1987-08-11 1996-02-14 日本化薬株式会社 ヒアルロン酸の分画法
JPH01210401A (ja) * 1988-02-17 1989-08-24 Mitsubishi Rayon Co Ltd 酸性多糖類の分離法
JPH0723317B2 (ja) * 1988-03-17 1995-03-15 生化学工業株式会社 角膜上皮層障害症治療剤
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
JP2731545B2 (ja) * 1988-10-12 1998-03-25 電気化学工業株式会社 ヒアルロン酸の精製方法

Also Published As

Publication number Publication date
FI925756A0 (fi) 1992-12-18
SK377192A3 (en) 1995-06-07
PL297297A1 (en) 1993-09-06
BR9205240A (pt) 1993-08-31
EP0535200B1 (en) 1999-11-03
EP0535200A1 (en) 1993-04-07
RU2128666C1 (ru) 1999-04-10
SG46515A1 (en) 1998-02-20
CZ282248B6 (cs) 1997-06-11
IT1247175B (it) 1994-12-12
NO924873D0 (no) 1992-12-16
FI925756A (fi) 1992-12-18
SK280191B6 (sk) 1999-09-10
IL113453A (en) 1995-07-31
ITPD910077A1 (it) 1992-10-19
ATE186307T1 (de) 1999-11-15
HUT63186A (en) 1993-07-28
IL101611A (en) 1996-06-18
FI104973B (fi) 2000-05-15
JP2580458B2 (ja) 1997-02-12
HU215193B (hu) 1998-10-28
NO924873L (no) 1993-02-19
HU9204012D0 (en) 1993-03-29
IL113453A0 (en) 1995-07-31
DE69230242D1 (de) 1999-12-09
WO1992018543A1 (en) 1992-10-29
US5559104A (en) 1996-09-24
NO305520B1 (no) 1999-06-14
DK0535200T3 (da) 2000-05-08
GR3032434T3 (en) 2000-05-31
CZ377192A3 (en) 1993-05-12
ITPD910077A0 (it) 1991-04-19
KR930700557A (ko) 1993-03-15
ES2092971T3 (es) 2000-01-01
PL168477B1 (pl) 1996-02-29
JPH05508183A (ja) 1993-11-18
DE69230242T2 (de) 2000-06-21
AU1576692A (en) 1992-11-17
ES2092971T1 (es) 1996-12-16
CA2084875C (en) 1998-01-06
AU653022B2 (en) 1994-09-15
KR0178544B1 (ko) 1999-04-01
CA2084875A1 (en) 1992-10-20

Similar Documents

Publication Publication Date Title
UA27229C2 (uk) Фракція гіалуронової кислоти або її солі для застосування в офтальмології, спосіб одержання фракції натрієвої солі гіалуронової кислоти та фармацевтичний препарат для використання в офтальмології
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
EP0339237A3 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
CA2118219A1 (en) Preparations of low molecular weight hyaluronic acid for stimulating bone formation
EP0244178A3 (en) Intraocular dosage compositions and method of use
ES2052893T3 (es) Preparado de n-acetil-glucosamina para administracion por via bucal.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
PT701449E (pt) Processo de preparacao de uma forma de dosagem solida oral contendo diclofenac
FR2669221B1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
ES2036174T3 (es) Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.
IE840977L (en) Pharmaceutical preparations
AU639746B2 (en) Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
JPS6413016A (en) Skin external preparation
IL85031A (en) Lyophilized aspoxicillin preparation and its manufacture
SE8306792L (sv) Nytt terapeutiskt preparat innehallande hydrerade ergotalkaloider och heparin
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
GR890100737A (el) Μέ?οδος παρασκευής μιας φαρμακευτικής συν?έσεως δι'οφ?αλμική χρήσιν η οποία περιλαμβάνει ένα υδατοδιαλυτό άλας δια προσ?ήκης οξέος ιμποπαμίνης.
CS8905180A1 (en) Method of hyaluronic acid's fractions or its salts preparation
NO931341L (no) Cyklopeptider, fremgangsmaate for fremstilling derav og deres anvendelse som legemiddel